Chair: Parth Narendran (GBR) 14:00 – 14:02 Welcome and Introduction Parth Narendran (GBR) 14:02 – 14:12 The Cost of Delayed Diagnosis – Establishing the Economic
Chairs: Jason Baker (USA), Nikolas Hillenbrand (DEU) 11:15 – 11:25 Teplizumab in treatment of T1D: Why Stage 2 autoimmune T1D management is changing Jason Baker
Chair: Chantal Mathieu (BEL) 18:00 – 18:05 Welcome and Introduction Chantal Mathieu (BEL) 18:05 – 18:20 A Hidden T1D Population: Accurate Diagnosis of Adults with
Chair: Partha Kar (GBR) 14:15 – 14:17 Welcome & Setting the Scene: Why Pathways Matter Now Partha Kar (GBR) 14:17 – 14:22 Building the Blueprint:
Chair: Fiona Adshead (GBR) 11:30 – 11:40 An underestimated impact: The environmental footprint in diabetes Fiona Adshead (GBR) 11:40 – 11:50 Moving towards more sustainability
Chair: Colin Dayan (GBR) 13:00 – 13:10 Treating the cause: The case for immunotherapy in T1D management Colin Dayan (GBR) 13:10 – 13:25 Defining the
Chairs: Luis Castaño (ESP), Ezio Bonifacio (DEU) Roundtable 1: Emerging T1D testing platforms to support scalable T1D early detection 11:30 – 11:35 Introduction Luis Castaño (ESP)
Chair: Partha Kar (GBR) 10:00 – 10:05 Introduction Partha Kar (GBR) 10:05 – 10:15 Core functioning: Therapeutic foundations with insulin therapy Andrej Janež (SVN) 10:15